These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 12007905)

  • 1. Androgen deficiency: menopause and estrogen-related factors.
    Sarrel PM
    Fertil Steril; 2002 Apr; 77 Suppl 4():S63-7. PubMed ID: 12007905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic aspects of natural and surgical menopause.
    Bachmann G
    J Reprod Med; 2001 Mar; 46(3 Suppl):307-15. PubMed ID: 11310451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens and antiandrogens.
    Schneider HP
    Ann N Y Acad Sci; 2003 Nov; 997():292-306. PubMed ID: 14644837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of estrogen/androgen regimens.
    Simon JA
    J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen replacement in menopause.
    Burd ID; Bachmann GA
    Curr Womens Health Rep; 2001 Dec; 1(3):202-5. PubMed ID: 12112971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosexual effects of menopause: role of androgens.
    Sarrel PM
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S319-24. PubMed ID: 10076172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estrogen/androgen therapy on bone mineral density parameters.
    Notelovitz M
    J Reprod Med; 2001 Mar; 46(3 Suppl):325-31. PubMed ID: 11304880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens in postmenopausal women: production, possible role, and replacement options.
    Lobo RA
    Obstet Gynecol Surv; 2001 Jun; 56(6):361-76. PubMed ID: 11466487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential anabolic effects of androgens on bone.
    Kearns AE; Khosla S
    Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S14-8. PubMed ID: 15065633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocrine transition around menopause--a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women.
    Overlie I; Moen MH; Morkrid L; Skjaeraasen JS; Holte A
    Acta Obstet Gynecol Scand; 1999 Aug; 78(7):642-7. PubMed ID: 10422913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen cotherapy in menopause: evolving benefits and challenges.
    Bachmann GA
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 2):S308-11. PubMed ID: 10076169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy in the climacteric: benefits beyond sexuality.
    Maia H; Casoy J; Valente J
    Gynecol Endocrinol; 2009 Jan; 25(1):12-20. PubMed ID: 19165658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens in women before and after the menopause and post bilateral oophorectomy: clinical effects and indications for testosterone therapy.
    Davey DA
    Womens Health (Lond); 2012 Jul; 8(4):437-46. PubMed ID: 22757734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women.
    Davis SR; Robinson PJ; Moufarege A; Bell RJ
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):541-7. PubMed ID: 22106826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen insufficiency in women: summary of critical issues.
    Braunstein GD
    Fertil Steril; 2002 Apr; 77 Suppl 4():S94-9. PubMed ID: 12007911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic use of androgens in women.
    Davis SR
    J Steroid Biochem Mol Biol; 1999; 69(1-6):177-84. PubMed ID: 10418991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
    Basaria S; Dobs AS
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4743-52. PubMed ID: 16984993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.